Vascular Malformations of the Central Nervous System: Case Studies

NEUROLOGY BOARD REVIEW MANUAL PUBLISHING STAFF PRESIDENT, PUBLISHER Bruce M.White EXECUTIVE EDITOR Debra Dreger SENIOR EDITOR Miranda J. Hughes, PhD ASSISTANT EDITOR Melissa Frederick EDITORIAL ASSISTANT Rita E. Gould SPECIAL PROGRAMS DIRECTOR Barbara T.White, MBA PRODUCTION DIRECTOR Suzanne S. Banish PRODUCTION ASSOCIATES Tish Berchtold Klus Christie Grams PRODUCTION ASSISTANT Mary Beth Cunney ADVERTISING/PROJECT MANAGER Patricia Payne Castle NOTE FROM THE PUBLISHER: This publication has been developed without involvement of or review by the American Board of Psychiatry and Neurology. Endorsed by the Association for Hospital Medical Education The Association for Hospital Medical Education endorses HOSPITAL PHYSICIAN for the purpose of presenting the latest developments in medical education as they affect residency programs and clinical hospital practice. Vascular Malformations of the Central Nervous System: Case Studies Series Editor: Milind J. Kothari, DO Associate Professor of Neurology Director, Neurology Residency Training Program Division of Neurology Pennsylvania State University College of Medicine Hershey, PA Contributing Author: Kevin M. Cockroft, MD Assistant Professor of Surgery/Neurosurgery Director, Cerebrovascular Surgery Division of Neurosurgery Pennsylvania State University College of Medicine Hershey, PA Table of Contents Introduction............................ 2 Arteriovenous Malformations.............. 2 Cavernous Angiomas..................... 8 Capillary Telangiectasias................. 11 Venous Angiomas....................... 11 Summary Points....................... 13 References............................ 13 Cover Illustration by Jean Gardner Copyright 2000, Turner White Communications, Inc., 125 Strafford Avenue, Suite 220, Wayne, PA 19087-3391, www.turner-white.com. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, mechanical, electronic, photocopying, recording, or otherwise, without the prior written permission of Turner White Communications, Inc. The editors are solely responsible for selecting content. Although the editors take great care to ensure accuracy, Turner White Communications, Inc., will not be liable for any errors of omission or inaccuracies in this publication. Opinions expressed are those of the authors and do not necessarily reflect those of Turner White Communications, Inc. Neurology Volume 5, Part 4 1

NEUROLOGY BOARD REVIEW MANUAL Vascular Malformations of the Central Nervous System: Case Studies Contributing Author: Kevin M. Cockroft, MD Assistant Professor of Surgery/Neurosurgery Director, Cerebrovascular Surgery Division of Neurosurgery Pennsylvania State University College of Medicine Hershey, PA I. INTRODUCTION Vascular malformations of the central nervous system (CNS) represent a heterogeneous group of lesions with various natural histories and treatments. CNS vascular malformations (Table 1) are commonly classified as belonging to 1 of 4 categories: (1) arteriovenous malformations (AVMs), (2) cavernous angiomas (ie, cavernomas, cavernous malformations), (3) capillary telangiectasias, and (4) venous angiomas (ie, developmental venous anomalies). 1 Based on autopsy series, the incidence of venous angiomas is approximately 2%, AVMs are 1%, capillary telangiectasias are 0.7%, and cavernous angiomas are 0.4%. 2 AVMs and cavernous angiomas commonly present with hemorrhage, seizures, or progressive neurologic deficit; treatment is often required. In contrast, capillary telangiectasias and venous angiomas are almost always incidental and/or asymptomatic and thus rarely require treatment. This manual describes the presentation, diagnosis, and treatment of all 4 CNS vascular malformations. Two case patients are presented to highlight specific features of the management of patients with AVMs or cavernous angiomas. II. ARTERIOVENOUS MALFORMATIONS CASE PATIENT 1 PRESENTATION Patient 1 is a 40-year-old woman with a several-year history of headaches, initially believed to be menstrual migraines. Soon after her fortieth birthday, she experienced an increase in the severity and frequency of her headaches. Later, she noticed episodes in which her vision on the left became cloudy and she saw spots. On examination, a partial left visual field defect is noted. A computed tomography (CT) scan reveals a mass in the right occipital lobe, which enhances after contrast administration (Figures 1A and 1B). A subsequent magnetic resonance image (MRI) reveals a lesion comprised of multiple flow-voids (Figure 1C). Patient 1 is referred for an arteriogram, which demonstrates a 3- to 4-cm high-flow AVM in the right parieto-occipital region (Figure 2A). GENERAL PRINCIPLES Presentation AVMs commonly present with which of the following signs or symptoms? 2 Hospital Physician Board Review Manual

Table 1. Vascular Malformations of the Central Nervous System Most Common Diagnostic Category Histopathology Presentations Tests Treatments AVM, high-flow AVM Primitive arteries and Hemorrhage CT Microsurgical resection veins without intervening capillaries but Seizures MRI Endovascular embolization Angiography Stereotactic radiosurgery with intervening brain parenchyma Cavernous angioma (cavernoma, cavernous hemangioma) Capillary telangiectasia Venous angioma (developmental venous anomaly) AVM = arteriovenous malformation; CT = computed tomography; MRI = magnetic resonance imaging. *May be associated with cavernous angioma. Dilated venous sinusoids without intervening brain parenchyma Cluster of dilated capillaries lacking muscle or elastic fibers Anomalous radial network of histologically normal veins Seizures Hemorrhage Clinically silent Clinically silent* CT MRI Angiographically occult Possibly seen on MRI Angiographically occult Usually found at autopsy Contrast CT MRI Angiography Microsurgical resection (possibly radiosurgery) No intervention necessary No intervention necessary A) Headache B) Seizures C) Hemorrhage D) Progressive neurologic deficit E) All of the above The correct answer is E. Hemorrhage is the most common presentation in patients with cerebral AVMs, occurring in 50% to 60% of patients. 3,4 Seizures are the next most frequent presentation, occurring in 11% to 33% of patients. 5 About 5% to 35% of patients may experience the onset of a new type of headache before the discovery of their AVM. 5 A small percentage of patients develop a progressive neurologic deficit. Neonates may occasionally present with high-output heart failure secondary to shunting through the AVM; vein of Galen malformations commonly present in this manner. AVMs, or more specifically pial high-flow AVMs, are congenital lesions, thought to arise during the first trimester of fetal development. They consist of primitive arteries directly connected to veins without an intervening capillary network. Dysplastic brain is present between the vessels in the core or nidus of the AVM (Figure 3). AVMs are usually fed by multiple arterial branches, although outflow is commonly provided by only 1 or 2 dilated veins. The high-pressure and highflow nature of these lesions makes them prone to hemorrhage. In addition, the shunting of arterial blood directly into the venous system can lead to poor perfusion and ischemia in the surrounding brain. Natural History When compared with intracranial aneurysms, the yearly rate of rupture from a high-flow AVM: A) Is less than that of an aneurysm B) Is equal to that of an aneurysm C) Is greater than that of an aneurysm D) Cannot be compared because AVMs never rupture E) Cannot be compared because aneurysms never rupture The correct answer is C. Unfortunately, the natural history of AVMs in particular the rate of hemorrhage remains poorly understood. Of the 4 categories Neurology Volume 5, Part 4 3

A B Figure 1. Axial CT and MRI scans of patient 1 s brain. (A) The noncontrast CT image shows a vague area of hyperdensity (arrow) in the right occipital lobe. (B) This region densely enhances after contrast administration. (C) The axial FLAIR MRI scan demonstrates a collection of multiple flow-voids in the right occipital lobe. CT = computed tomography; FLAIR = fluid attenuated inversion recovery; MRI = magnetic resonance imaging. C of vascular malformations discussed in this manual, perhaps the most is known about high-flow AVMs. In a longterm follow-up study, Ondra and colleagues 6 found an annual rate of hemorrhage for high-flow AVMs of 2% for asymptomatic lesions and 4% for symptomatic malformations; this study has been quoted frequently. This same group placed the mortality rate at 1% per year, with a combined major morbidity and mortality of 2.7% per year. Other studies have suggested a 10% to 15% risk of death and a 20% to 30% risk of major morbidity with each hemorrhage. 3,4,7,8 In comparison, the risk of hemorrhage from an intracranial aneurysm is reported to be 1% to 2% per year, 9 11 with a 30-day mortality rate after aneurysmal subarachnoid hemorrhage of almost 50%. 12,13 A history of seizures does not appear to adversely affect the chances of AVM re-hemorrhage. 6 However, 4 Hospital Physician Board Review Manual

various other factors, including small size of the AVM, venous stenosis or ectasia, periventricular location, history of previous hemorrhage, and the presence of intranidal or associated aneurysms have all been linked to an increased risk of hemorrhage. 14 18 The relationship between aneurysms and AVMs appears to be more than sporadic, with several studies reporting a 2.7% to 14% incidence of aneurysms in patients with AVMs. 19 23 In some situations, because of the high risk of mortality associated with aneurysm rupture, appropriate management of these patients may require definitive treatment of the aneurysm before AVM obliteration. 19 Diagnosis If treatment is contemplated in a symptomatic patient with an apparent AVM visible on CT and MRI, what would be the next most appropriate diagnostic study? A) Xenon CT scan B) Angiography C) Perfusion or diffusion MRI D) Lumbar puncture E) MRI spectroscopy The correct answer is B. AVMs usually present during the third or fourth decades of life. A CT or MRI scan is usually the initial diagnostic study of choice. On CT scan, high-flow AVMs appear as a cluster of densely enhancing vascular structures (Figure 1). A noncontrast CT is the study of choice to detect hemorrhage from an AVM (Figure 4) because MRI scans will only show blood in the AVM and not the hemorrhage itself. However, MRI provides improved resolution when compared with CT and allows viewing of the AVM in multiple planes. On MRI, AVMs appear as a collection of flow voids, visible even on noncontrast images (Figure 1C). MRI is particularly useful for planning approaches for microsurgical resection and treatment with stereotactic radiosurgery. After a lesion suspicious for AVM is found on CT or MRI, an angiogram is necessary if any treatment is required. High-resolution, 4-vessel, digital subtraction angiography is the gold standard for AVM evaluation. Angiography continues to provide the best means of evaluating an AVM s structure, including assessing the character, type, and location of its feeding arteries and draining veins. The dynamic nature of angiography also enables an assessment of the flow characteristics of the malformation. The hallmark of a high-flow AVM on angiography is the direct arteriovenous connection, giving rise to the rapid filling of the draining vein(s) (Figures 2A, 2B, and 2C). This rapid venous filling, referred to as early venous drainage, is readily seen during the arterial phase when normal veins are not visible. Because of the small risk of complications related to angiography, many advocate the performance of angiography only when treatment is contemplated. CASE PATIENT 1 FOLLOW-UP Patient 1 appears to have a symptomatic high-flow AVM. Given her relatively young age, she is felt to be at significant risk for morbidity secondary to the AVM during the remainder of her life; therefore, treatment is recommended. A multidisciplinary approach using endovascular embolization followed by microsurgical resection is selected based on the patient s clinical status as well as the location and size of the AVM. Followup arteriograms obtained after embolization and surgery demonstrate a decrease in the size of the AVM followed by complete obliteration of the lesion (Figures 2B and 2C). Surgical pathology confirms the diagnosis of a high-flow AVM (Figure 3). Postoperative clinical examination reveals a persistent left visual field defect. GENERAL PRINCIPLES Treatment Clinical management of high-flow AVMs may include all of the following EXCEPT: A) Microsurgical resection B) Stereotactic radiosurgery C) Observational follow-up D) Needle biopsy and aspiration E) Endovascular embolization The correct answer is D. Three major modalities are available for the treatment of AVMs: microsurgical resection, endovascular embolization, and stereotactic radiosurgery. Needle biopsy and aspiration are strongly contraindicated when a vascular malformation is suspected because of the high risk of inducing hemorrhage. In some situations, the risks of treatment may outweigh the benefits, and simple observational follow-up may be recommended. Microsurgical resection can provide an immediate cure and eliminate the future risk of hemorrhage. However, surgical resection may be limited by the size of the lesion or by the AVM s location within deep or eloquent brain structures. In a retrospective series of 100 surgically cured AVMs, Spetzler and Martin 24 reported minor postoperative deficits in 5% to 19% of patients and major deficits in 4% to 12%. The incidence of postoperative deficits depended on the location, size, and Neurology Volume 5, Part 4 5

A B Figure 2. Lateral views of ICA angiograms obtained during the diagnosis and treatment of patient 1. (A) Pretreatment angiogram shows an AVM in the occipital lobe fed by dilated branches of the middle cerebral artery (solid arrows) and drained by a single superficial vein (open arrow). During this arterial phase image, minimal contrast remains in the ICA, suggesting extremely high flow. The draining vein is visible at this time, confirming early venous drainage. (B) After embolization, flow is slowed and the size of the nidus (arrow) has been greatly reduced. (C) Postoperatively, the nidus is no longer visible and early venous drainage is not apparent; however, some dilated arteries remain (arrow). AVM = arteriovenous malformation; ICA = internal carotid artery. C Figure 3. An H&E-stained histologic section of an arteriovenous malformation from patient 1. Note the thick-walled abnormal arteries (solid arrow) and the intervening dysplastic brain (open arrow). H&E = hematoxylin and eosin. 6 Hospital Physician Board Review Manual

type of venous drainage of the AVM. Based on their results, the authors proposed an AVM grading system, which remains in widespread use. Although endovascular embolization alone may cure some small AVMs, this technique is usually used as an adjuvant therapy to reduce the size of large AVMs before microsurgical resection or stereotactic radiosurgery. Various materials have been used to endovascularly occlude AVMs; the most popular methods currently in use include cyanoacrylate-based glues, polyvinyl alcohol particles, and detachable platinum coils. A large AVM may require multiple sessions of embolization before surgery or radiation. Stereotactic radiosurgery is often used to treat AVMs in deep locations or those situated within eloquent brain structures. However, radiosurgery is limited by size, with the best results seen in lesions smaller than 3 cm in maximal dimension. The 3 major delivery systems for focused beam radiosurgery include linear accelerator based (LINAC) programs, gamma radiation units (gamma knife), and heavy particle (helium ion or proton beam) systems. Various clinical series have demonstrated efficacy for all of these techniques. Three years after treatment, cure rates of 80% to 95% have been reported for lesions smaller than 3 cm that were treated with 20 to 25 GyE. 25 32 These series also reported low complication rates of 2.5% to 4.5% for permanent neurologic deficits and 2.5% to 4.5% for transient deficits. Most complications arose from radiation toxicity and necrosis in the surrounding brain. Aside from the toxicity issues, the major disadvantage of radiosurgery is that during AVM obliteration, the risk of hemorrhage persists and may even be increased. 33 36 Regardless of the treatment modality used, once complete obliteration of the AVM has been documented by a post-treatment angiogram, the patient is generally considered cured. The use of routine delayed follow-up angiography is controversial. Certainly, late follow-up angiography may be required as part of a clinical research protocol or in cases of clinical uncertainty. Neurologic deficits present after AVM treatment tend to improve over time, but full resolution is not typical. Long-term neurologic follow-up may be necessary in selected patients, particularly those with persistent seizures or severe neurologic deficits. The decision about whether and how to treat a patient with an AVM must be based on various factors. The patient s clinical situation and the natural history of the lesion are perhaps the most important considerations when a physician decides whether to treat. The exact method of treatment can then be planned after a careful analysis of the AVM s radiographic characteristics. Except A B Figure 4. Hemorrhage from an arteriovenous malformation.(a) Noncontrast axial CT scan of a young woman showing an acute hemorrhage in the left thalamus. (B) Lateral view of a vertebral artery injection from her subsequent angiogram confirms the presence of an arteriovenous malformation. Note the associated aneurysm (arrow). CT = computed tomography. Neurology Volume 5, Part 4 7

for very small AVMs, optimal treatment today often uses a combination of modalities; the best results are typically achieved at specialized centers where all 3 major treatment modalities are available. Regardless of the modality used, the AVM must be completely obliterated (as documented by angiography) to eliminate any future risk of hemorrhage. Partial treatment is not an effective means of preventing future hemorrhage. Spinal AVMs AVMs can also occur in the spinal cord and represent about 4% of intraspinal masses. 37 Although these lesions may be purely intradural and intramedullary, most are located within the dura rather than the CNS itself. Dural AVMs, especially the intracranial variety, are widely regarded as predominantly acquired lesions, with a natural history very different from the pial AVMs previously discussed. In general, patients with spinal AVMs present with back pain associated with a progressive neurologic deficit. However, about 10% to 20% of younger patients present with the sudden onset of myelopathy secondary to hemorrhage. 38,39 Spinal angiography is challenging and relatively high risk but is required to confirm the diagnosis. At angiography, many spinal AVMs are actually found to be an arteriovenous fistula, with only a single arteriovenous connection. Successful treatment may then be accomplished by either endovascular embolization or microsurgical resection of the nidus or fistula. III. CAVERNOUS ANGIOMAS CASE PATIENT 2 PRESENTATION Patient 2 is a 31-year-old, right-handed graduate student with a known cavernous angioma, who notes the sudden onset of partial left visual field loss while working on his thesis. Seven years previously, patient 2 was found to have a cavernous angioma when he presented with a dense left homonymous hemianopsia, which had subsequently resolved. Patient 2 s family history is remarkable for an uncle with an intracranial hemorrhage and a sister with a known cavernous angioma. On examination of patient 2, a partial left visual field defect is noted to confrontation and is confirmed by formal visual field testing. An MRI scan demonstrates an irregularly enhancing mass in the medial right temporal lobe. The T1-weighted images reveal that the mass is composed of various signal intensities; on the long TRweighted images, a rim of hypointense signal surrounding the lesion is apparent (Figures 5A and 5B). GENERAL PRINCIPLES Presentation Cavernous angiomas (cavernomas) may present with which of the following signs, symptoms, or both? A) Hemorrhage B) Progressive neurologic deficit C) Seizures D) Headache E) All of the above The correct answer is E. Patients with supratentorial cavernous malformations most commonly present with seizures. 40 The second and third most common presentations are hemorrhage and headaches, respectively. Most infratentorial cavernomas present with progressive neurologic deficits, 41 possibly as a result of repeated minor hemorrhages. Although most cavernomas are sporadic in nature, about 15% of patients have a familial form, which localizes to chromosome 7q and is inherited in an autosomal dominant manner. 42,43 Most patients with the familial form have multiple malformations. Diagnosis The radiographic appearance of cavernous angiomas may include all of the following EXCEPT: A) Calcification on CT scan B) Hypointense periphery on T2-weighted MRI C) Feeding arteries and draining veins on angiography D) MRI evidence of multiple hemorrhages of different ages E) Multiplicity on CT or MRI The correct answer is C. Cavernous angiomas or cavernomas are part of a group of vascular malformations collectively referred to as angiographically occult vascular malformations (AOVMs) or cryptic malformations. In other words, these vascular malformations are not visible on angiography. Also included in this category are capillary telangiectasias and some histologically true AVMs, which may have burned out through thrombosis or previous hemorrhage. On histologic examination, cavernous angiomas appear as a collection of low-flow venous sinusoids without any intervening neural parenchyma (Figure 6). There are no large feeding arteries or draining veins. The brain immediately surrounding the malformation is usually gliotic and stained with hemosiderin. Like high-flow AVMs, cavernomas may occur anywhere in the CNS. However, lesions in the spinal cord are rare. 44 8 Hospital Physician Board Review Manual

A B C Figure 5. Axial MRI scans of a cavernous angioma from patient 2. (A) The T 1 -weighted image shows an irregularly enhancing mass (arrow) of various signal intensities in the medial right temporal lobe. (B) On a long TR image, a hypointense ring (arrow) can be seen around the malformation as a result of hemosiderin deposition in the surrounding brain. (C) A postoperative T 1 image shows a gross total resection of the lesion (arrow). MRI = magnetic resonance imaging. On CT scan, these malformations appear as a heterogeneous collection of various densities. Calcification is frequently present, as is evidence of hemorrhage. On routine MRI, the hallmark of a cavernous angioma is evidence of multiple hemorrhages that occurred over time (ie, at different ages), giving the lesion a popcorn like appearance. On long TR images, a hypointense rim is seen, resulting from hemosiderin deposition in the brain surrounding the malformation (Figures 5A and 5B). A gradient-recalled echo (GRE) sequence further accentuates this hemosiderin blossoming and is therefore ideal for screening for even the smallest of malformations (Figures 7A, 7B, and 7C). Natural History Like vascular malformations in general, the natural history of cavernous malformations is poorly understood. Estimates of yearly hemorrhage rates range anywhere from less than 1% to almost 30%. 40,45 53 However, when only prospectively documented symptomatic hemorrhages are recorded, a narrower range of 2.6% to 4.2% is apparent. 54,55 Female sex, pregnancy, previous symptomatic hemorrhage, association of the cavernoma with a venous angioma, and deeply located (thalamus, basal ganglia, and brainstem) malformations have all been associated with an increased risk of hemorrhage. 40,47,50,51,56 58 In addition, some authors have found a higher rate of bleeding for familial cavernous angiomas, suggesting that their natural history may be worse than that of their sporadic counterparts. 54 Many Figure 6. Trichrome-stained histologic section of a cavernous angioma from patient 2. Note the thin-walled venous sinusoids (arrow). No intervening brain is visible. hemorrhages from cavernous malformations are clinically silent and fatal hemorrhages are rare, yielding a low hemorrhagic risk in contrast to the high risk associated with high-flow AVMs. Aside from hemorrhage, the major cause of morbidity from cavernous angioma is seizures. One recent study put the yearly risk of developing new seizures at 2.4%, with an overall yearly risk of seizures in patients with cavernous angiomas of 4.8%. 54 CASE PATIENT 2 FOLLOW-UP Given the natural history of this suspected cavernous angioma, as well as patient 2 s young age and his history Neurology Volume 5, Part 4 9

A B C Figure 7. Axial GRE images of a young woman with a family history of cavernous angiomas. (A, B, and C) Images show at least 5 separate areas (arrows) of focal hypointensity (hemosiderin blossoming) consistent with 5 different cavernous angiomas. GRE = gradientrecalled echo. of 2 symptomatic hemorrhages, treatment is recommended. Patient 2 undergoes a gross total microsurgical resection of the lesion (Figure 5C). Final pathology confirms the diagnosis of a cavernous angioma (Figure 6). Postoperative examination reveals a persistent left visual field defect. Serial visual field tests that are performed during the next several months show slight improvement in the field loss. GENERAL PRINCIPLES Treatment Which of the following treatments is most effective for a superficially located symptomatic cavernous angioma? A) Endovascular embolization B) Stereotactic radiosurgery C) Needle biopsy and aspiration D) Microsurgical resection E) Whole brain irradiation The correct answer is D. As with high-flow AVMs, decisions regarding the appropriate management of cavernous malformations are made more difficult by the limited understanding of their natural history. In addition, the angiographically occult nature of these lesions eliminates endovascular therapy as a treatment option. The low risk of hemorrhage from asymptomatic cavernous malformations suggests that these lesions do not need to be treated. In the absence of definitive treatment, the avoidance of anticoagulants and antiplatelet agents is often recommended. In symptomatic patients, microsurgical resection is the only definitive treatment and is therefore reserved mainly for those with progressive neurologic deficits, medically intractable seizures, and/or severe headaches. 2,5,59 For surgically accessible lesions, resection can be quite straightforward, given the lack of large feeding arteries and the presence of a gliotic plane around the malformation. Surgical results are generally good, with most patients (75% to 95%) demonstrating clinical improvement or at least stable deficits. 59 62 For deeply located lesions, surgical resection is more challenging and stereotactic localization techniques may be useful. However, even high-risk lesions in the brainstem, thalamus, or basal ganglia can be surgically resected with acceptable morbidity. 51,62 64 In the brainstem, it may be necessary to wait until the lesion presents itself to the pial surface in order to establish a safe pathway for resection. 51,62 Treatment of cavernous malformations with stereotactic radiosurgery is controversial. Some studies have reported an increase in the rate of hemorrhage after radiosurgery, although others claim an apparent decrease in the bleeding rate, especially at longer followup intervals. 53,65,66 To make matters worse, radiationinduced complications have been frequent, with 9% to 21.5% of patients experiencing radiation injury or a new neurologic deficit and 3% to 4.5% dying during followup. 53,65,66 Currently, radiosurgery is probably best reserved for patients with symptomatic deep-seated AOVMs that do not present to a pial or ventricular surface and are therefore considered inoperable. Cure after surgical resection is best documented by serial MRI scanning. However, proof of cure after radiosurgery may be difficult to ascertain because the MRI appearance of the lesion may change only minimally. As such, careful long-term clinical and radiographic followup is probably warranted after any form of treatment. 10 Hospital Physician Board Review Manual

IV. CAPILLARY TELANGIECTASIAS Capillary telangiectasias consist of a network of abnormally dilated capillaries with intervening brain parenchyma. There are no abnormal feeding arteries, although drainage into a central enlarged vein has been reported. 67 These lesions are thought to be clinically silent and are usually discovered incidentally at autopsy. 5,68,69 On gross examination, the lesions appear similar to a cluster of petechial hemorrhages (Figure 8A). On microscopic sections, hemorrhage or gliosis in the brain parenchyma are not apparent; however, dilated capillary vessels devoid of muscle or elastic fibers can be seen (Figure 8B). Most capillary telangiectasias are found in the pons, and multiple lesions are common, similar to cavernous malformations. Capillary telangiectasias are not visible on angiography, constituting about 3.8% of AOVMs. 70 Occasionally, they may show up as incidental findings on MRI, where the malformations appear as punctate areas of decreased signal intensity on T2-weighted images and may demonstrate contrast enhancement with gadolinium administration. 71 Because these lesions are thought to be clinically silent, no treatment is required. Capillary telangiectasias are of interest mainly because they may represent a potential developmental link with cavernous angiomas. 72,73 V. VENOUS ANGIOMAS A B Figure 8. Capillary telangiectasia. (A) Gross autopsy specimen showing an incidentally found capillary telangiectasia in the pons. (B) An H&E-stained microscopic specimen from the same patient shows an abnormal cluster of capillaries of various sizes. H&E = hematoxylin and eosin. Venous angiomas, also known as developmental venous anomalies (DVAs), are anomalous collections of normally functioning draining veins. On histologic examination, the veins themselves are normal and they are surrounded by normal brain parenchyma. Most are located in the deep white matter of the cerebral hemispheres or the cerebellum. 74 No abnormal arteries are associated with these lesions; hemorrhage or calcification is unusual. 75 The malformations eventually empty into the deep or superficial venous system. 76 Venous angiomas are best visualized during the venous phase of angiography. They appear as a collection of smaller veins converging into a larger vein in a radial or spoked-wheel pattern, giving rise to the classic angiographic term of caput medusae (Figures 9A and 9B). Venous angiomas are easily distinguished from high-flow AVMs by their angiographic features. DVAs lack feeding arteries and, unlike AVM draining veins, these are seen during the venous phase of the angiogram instead of early in the arterial phase. Venous angiomas are also well visualized on contrastenhanced CT scans and show up as contrast-enhancing flow-voids on MRI (Figures 10A and 10B). Like capillary telangiectasias, venous angiomas are thought to be clinically silent. 68,69 In fact, obliteration or removal of a DVA by any modality is likely to result in a venous infarction because the anomaly is providing venous drainage for a normal brain. 77,78 The situation is somewhat complicated by the high association of venous angiomas with cavernous angiomas. 78 Various symptoms including headache, seizures, hemorrhage, and progressive neurologic deficits have all been previously ascribed to venous angiomas. 78 80 However, after more rigorous examination with CT and MRI, these symptoms have in general been attributed to associated cavernous angiomas, rather than the Neurology Volume 5, Part 4 11

A B Figure 9. Lateral views of a left ICA injection of a patient with an incidentally found venous angioma. (A) The arterial phase appears normal. (B) During the venous phase, a complex of radially converging abnormal veins (caput medusae) is seen (arrow), consistent with a developmental venous anomaly or venous angioma. ICA = internal carotid artery. A B Figure 10. Axial CT and MRI scans of an incidentally found developmental venous anomaly. (A) On contrast-enhanced CT scan, the malformation appears as an anomalous area of linear enhancement (arrow). (B) A T 2 -weighted MRI scan of the same patient shows a linear flow void (arrow). CT = computed tomography; MRI = magnetic resonance imaging. 12 Hospital Physician Board Review Manual

venous anomaly itself. As mentioned previously, symptomatic cavernous angiomas may be successfully treated with microsurgical resection. However, care must be taken to avoid resection of any associated venous anomaly to prevent postoperative venous infarction. VI. SUMMARY POINTS CNS vascular malformations include AVMs, cavernous angiomas, capillary telangiectasias, and venous angiomas. AVMs and cavernous angiomas most commonly present with hemorrhage, seizures, progressive neurologic deficit, or headaches. Capillary telangiectasias and venous angiomas are usually clinically silent. AVMs are visible on CT, MRI, and angiography. Cavernous malformations are visible on CT and MRI but are angiographically occult. Capillary telangiectasias are occasionally visible on MRI but are most commonly found incidentally at autopsy. Venous angiomas can be seen on MRI, contrast-ct, and angiography. On a yearly basis, AVMs hemorrhage more frequently than do intracranial aneurysms. However, the morbidity and mortality associated with aneurysm rupture is considerably greater than that associated with AVM hemorrhage. AVMs may be treated with microsurgical resection, endovascular embolization, stereotactic radiosurgery, or a combination of these modalities. Microsurgical resection remains the treatment of choice for most symptomatic cavernous angiomas. Capillary telangiectasias and venous angiomas do not require treatment. Resection of a venous angioma may actually lead to venous infarction. REFERENCES 1. McCormick WF. The pathology of vascular ( arteriovenous ) malformations. J Neurosurg 1966;24:807 816. 2. Huhn S, Rigamonti D, Hsu F. Indications for surgical intervention In: Awad IA, Barrow DL, eds. Cavernous Malformations. Park Ridge, IL: American Association of Neurological Surgeons; 1993:87 99. 3. Drake CG. Cerebral arteriovenous malformations: considerations for and experience with surgical treatment in 166 cases. Clin Neurosurg 1979;26:145 208. 4. Perret G, Nishioka H. Report on the cooperative study of intracranial aneurysms and subarachnoid hemorrhage. Section VI. Arteriovenous malformations. An analysis of 545 cases of cranio-cerebral arteriovenous formulations and fistulae reported to the cooperative study. J Neurosurg 1966;25:467 490. 5. Lewis A, Sathi S, Tew J Jr. Intracranial vascular malformations. In: Grossman RG, Loftus CM, eds. Principles of neurosurgery. 2nd ed. Philadelphia: Lippincott-Raven; 1999:339 351. 6. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990;73:387 391. 7. Luessenhop A. Natural history of cerebral arteriovenous malformations. In: Wilson CB, Stein BM, eds. Intracranial arteriovenous malformations. Baltimore: Williams and Wilkins; 1984:12 23. 8. Mohr J. Neurological manifestations and factors related to therapeutic decisions. In: Wilson CB, Stein BM, eds. Intracranial arteriovenous malformations. Baltimore: Williams and Wilkins; 1984:1 11. 9. Jane JA, Kassel NF, Torner JC, Winn HR. The natural history of aneurysms and arteriovenous malformations. J Neurosurg 1985;62:321 323. 10. Juvela S, Porras M, Heiskanen O. Natural history of unruptured intracranial aneurysms: a long follow-up study. J Neurosurg 1993;79:174 182. 11. Wiebers DO, Whisnant JP, Sundt TM Jr, O Fallon WM. The significance of unruptured intracranial saccular aneurysms. J Neurosurg 1987;66:23 29. 12. Ingall T, Wiebers D. Natural history of subarachnoid hemorrhage. In: Stroke: populations, cohorts, and clinical trials. Boston: Butterworth-Heinemann; 1993:174 186. 13. Broderick JP, Brott T, Tomsick T, et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 1993;78:188 191. 14. Spetzler RF, Hargraves RW, McCormick PW, et al. Relationship of perfusion pressure and size to risk of hemorrhage from arteriovenous malformations. J Neurosurg 1992;76:918 923. 15. Miyasaka Y, Yada K, Ohwada T, et al. An analysis of the venous drainage system as a factor in hemorrhage from arteriovenous malformations. J Neurosurg 1992;76: 239 243. 16. Marks MP, Lane B, Steinberg GK, Chang PJ. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology 1990;176:807 813. 17. Turjman F, Massoud T, Vinuela F, et al. Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery 1995;37:856 862. 18. Waltimo O. The relationship of size, density and localization of intracranial arteriovenous malformations to the type of initial symptom. J Neurol Sci 1973;19:13 19. 19. Cockroft KM, Thompson RC, Steinberg GK. Aneurysms Neurology Volume 5, Part 4 13

and arteriovenous malformations. Neurosurg Clin N Am 1998;9:565 576. 20. Batjer H, Suss RA, Samson D. Intracranial arteriovenous malformations associated with aneurysms. Neurosurgery 1986;18:29 35. 21. Higashi K, Hatano M, Yamashita T, et al. Coexistence of posterior inferior cerebellar artery aneurysm and arteriovenous malformation fed by the same artery. Surg Neurol 1979;12:405 408. 22. Paterson J, McKissock W. A clinical survey of intracranial angiomas with special reference to their mode of progression and surgical treatment: a report of 110 cases. Brain 1956;79:233 266. 23. Suzuki J, Onuma T. Intracranial aneurysms associated with arteriovenous malformations. J Neurosurg 1979;50: 742 746. 24. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65: 476 483. 25. Alexander E 3rd, Loeffler JS. Radiosurgery using a modified linear accelerator. Neurosurg Clin N Am 1992;3: 167 190. 26. Betti OO, Munari C, Rosler R. Stereotactic radiosurgery with the linear accelerator: treatment of arteriovenous malformations. Neurosurgery 1989;24:311 321. 27. Colombo F, Pozza F, Chierego G, et al. Linear accelerator radiosurgery of cerebral arteriovenous malformations: an update. Neurosurgery 1994;34:14 21. 28. Fabrikant JI, Levy RP, Steinberg GK, et al. Charged-particle radiosurgery for intracranial vascular malformations. Neurosurg Clin N Am 1992;3:99 139. 29. Friedman WA, Bova FJ. Linear accelerator radiosurgery for arteriovenous malformations. J Neurosurg 1992;77: 832 841. 30. Leksell L. Stereotactic radiosurgery. J Neurol Neurosurg Psychiatry 1983;46:797 803. 31. Lunsford LD, Kondziolka D, Bissonette D, et al. Stereotactic radiosurgery of brain vascular malformations. Neurosurg Clin N Am 1992;3:79 98. 32. Steiner L, Lindquist C, Adler JR, et al. Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg 1992;77:1 8. 33. Brown RD Jr, Wiebers DO, Forbes G, et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988;68:352 357. 34. Fults D, Kelly DL Jr. Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery 1984;15:658 662. 35. Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg 1983;58:331 337. 36. Steinberg GK, Chang SD, Levy RP, et al. Surgical resection of large incompletely treated intracranial arteriovenous malformations following stereotactic radiosurgery. J Neurosurg 1996;84:920 928. 37. Krayenbuhl H, Yasargil MG, McClintock HG. Treatment of spinal cord vascular malformations by surgical excision. J Neurosurg 1969;30:427 435. 38. Aminoff MJ, Logue V. The prognosis of patients with spinal vascular malformations. Brain 1974;97:211 218. 39. Tobin WD, Layton DD. The diagnosis and natural history of spinal cord arteriovenous malformations. Mayo Clin Proc 1976;51:637 646. 40. Robinson J, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg 1991;75:709 714. 41. Tew JM, Lewis AI, Reichert KW. Management strategies and surgical techniques for deep-seated supratentorial arteriovenous malformations. Neurosurgery 1995;36:1065 1072. 42. Gunel M, Awad IA, Anson J, Lifton RP. Mapping a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci U S A 1995;92:6620 6624. 43. Dubovsky J, Zabramski JM, Kurth J, et al. A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet 1995;4:453 458. 44. Cosgrove GR, Bertrand G, Fontaine S, et al. Cavernous angiomas of the spinal cord. J Neurosurg 1988;68:31 36. 45. Boecher-Schwarz HG, Grunert P, Guenthner M, et al. Stereotactically guided cavernous malformation surgery. Minim Invasive Neurosurg 1996;39:50 55. 46. Del Curling O Jr, Kelly DL Jr, Elster AD, Craven T. An analysis of the natural history of cavernous angiomas. J Neurosurg 1991;75:702 708. 47. Fritschi JA, Reulen HJ, Spetzler RF, Zabramski JM. Cavernous malformations of the brain stem. A review of 139 cases. Acta Neurochir (Wien) 1994;130:35 46. 48. Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg 1995;83:820 824. 49. Stea RA, Schicker L, King GA, Winfield JA. Stereotactic linear radiosurgery for cavernous angiomas. Stereotact Funct Neurosurg 1994;63:255 265. 50. Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422 432. 51. Zimmerman RS, Spetzler RF, Lee KS, et al. Cavernous malformations of the brain stem. J Neurosurg 1991;75:32 39. 52. Steinberg GK, Levy RP, Fabrikant JI, et al. Stereotactic helium ion Bragg peak radiosurgery for angiographically occult intracranial vascular malformations. Stereotact Funct Neurosurg 1991;57:64 71. 53. Kondziolka D, Lunsford LD, Flickinger JC, Kestle JR. Reduction of hemorrhage risk after stereotactic radiosurgery for cavernous malformations. J Neurosurg 1995; 83:825 831. 14 Hospital Physician Board Review Manual

54. Moriarity JL, Wetzel M, Clatterbuck RE, et al. The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery 1999;44:1166 1173. 55. Porter PJ, Willinsky RA, Harper W, Wallace MC. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg 1997;87:190 197. 56. Aiba T, Tanaka R, Koike T, et al. Natural history of intracranial cavernous malformations. J Neurosurg 1995; 83:56 59. 57. Pozzati E, Acciarri N, Tognetti F, et al. Growth subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. Neurosurgery 1996;38:662 670. 58. Robinson JR Jr, Awad IA, Magdinec M, Paranandi L. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery 1993;32:730 736. 59. Rigamonti D, Hsu F, Monsein L. Cavernous malformations and related lesions. In: Wilkins RH, Rengachary SS, eds. Neurosurgery. Vol 2. 2nd ed. New York: McGraw-Hill; 1996:2503 2508. 60. Villani RM, Arianta C, Caroli M. Cavernous angiomas of the central nervous system. J Neurosurg Sci 1989;33:229 252. 61. Yamasaki T, Handa H, Yamashita J, et al. Intracranial and orbital cavernous angiomas. A review of 30 cases. J Neurosurg 1986;64:197 208. 62. Steinberg GK, Chang SD, Gewirtz RJ, Lopez JR. Microsurgical resection of brainstem, thalamic, and basal ganglia angiographically occult vascular malformations. Neurosurgery 2000;46:260 271. 63. Bertalanffy H, Gilsbach JM, Eggart HR, Seeger W. Microsurgery of deep-seated cavernous angiomas: report of 26 cases. Acta Neurochir (Wien) 1991;108:91 99. 64. Fahlbusch R, Strauss C, Huk W. Pontine-mesencephalic cavernomas: indications for surgery and operative results. Acta Neurochir Suppl (Wien) 1991;53:37 41. 65. Amin-Hanjani S, Ogilvy CS, Candia GJ, et al. Stereotactic radiosurgery for cavernous malformations: Kjellberg s experience with proton beam therapy in 98 cases at the Harvard cyclotron. Neurosurgery 1998;42:1229 1238. 66. Chang SD, Levy RP, Adler JR Jr, et al. Stereotactic radiosurgery of angiographically occult vascular malformations: 14-year experience. Neurosurgery 1998;43:213 221. 67. Blackwood W. Two cases of benign cerebral telangiectasis. J Pathol Bacteriol 1941;52:209 212. 68. Garner TB, Curling O Jr, Kelly DL Jr, Laster DW. The natural history of intracranial venous angiomas. J Neurosurg 1991;75:715 722. 69. Kondziolka D, Dempsey PK, Lunsford LD. The case for conservative management of venous angiomas. Can J Neurol Sci 1991;18:295 299. 70. Lobato RD, Perez C, Rivas JJ, Cordobes F. Clinical, radiological, and pathological spectrum of angiographically occult intracranial vascular malformations. Analysis of 21 cases and review of the literature. J Neurosurg 1988; 68:518 531. 71. Rigamonti D, Drayer BP, Johnson PC, et al. The MRI appearance of cavernous malformations (angiomas). J Neurosurg 1987;67:518 524. 72. Awad IA, Robinson JR Jr, Mohanty S, Estes ML. Mixed vascular malformations of the brain: clinical and pathogenic considerations. Neurosurgery 1993;33:179 188. 73. Rigamonti D, Johnson PC, Spetzler RF, et al. Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery 1991; 28:60 64. 74. Sarwar M, McCormick WF. Intracerebral venous angioma. Case report and review. Arch Neurol 1978;35:323 325. 75. McCormick WF, Hardman JM, Boulter TR. Vascular malformations ( angiomas ) of the brain with special reference to those occurring in the posterior fossa. J Neurosurg 1968;28:241 251. 76. Huang Y, Robbins A, Patel S, et al. Cerebral venous malformations and a new classification of cerebral vascular malformations. In: Kapp JP, Schmidek HH, eds. The Cerebral Venous System and Its Disorders. New York: Grune and Stratton; 1984:373 474. 77. Sasaki O, Tanaka R, Koike T, et al. Excision of cavernous angioma with preservation of coexisting venous angioma. Case report. J Neurosurg 1991;75:461 464. 78. Rigamonti D, Spetzler RF, Medina M, et al. Cerebral venous malformations. J Neurosurg 1990;73:560 564. 79. Berenstein A, Choi I. Treatment of venous angiomas by direct alcohol injection. AJNR Am J Neuroradiol 1983; 4:1144. 80. Malik GM, Morgan JK, Boulos RS, Ausman JI. Venous angiomas: an underestimated cause of intracranial hemorrhage. Surg Neurol 1988;30:350 358. Copyright 2000 by Turner White Communications Inc., Wayne, PA. All rights reserved. Neurology Volume 5, Part 4 15